查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1558350

2030 年血管闭合装置市场预测：按产品、接取模式、应用、最终用户和地区进行的全球分析

Vascular Closure Devices Market Forecasts to 2030 - Global Analysis By Product, Access Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球血管闭合装置市场规模为 13 亿美元，预计在预测期内将以 8.3% 的复合年增长率成长，到 2030 年达到 21 亿美元。血管闭合装置 (VCD) 是一种用于密封或闭合血管穿孔的医疗装置，通常在血管造影术或经皮冠状动脉介入治疗等导管手术后使用。这些装置对于最大限度地减少出血、减少併发症以及透过加速穿刺部位的止血来加速恢復至关重要。 VCD 透过多种机制运行，包括机械压缩、组织黏合剂以及专用塞子或补片的部署。 VCD透过有效阻断血管入口，预防血肿、出血、感染疾病等併发症，让患者更快恢復正常活动。

据英国心臟基金会称，到 2024 年，全球将有约 6.2 亿人患有心臟或循环系统疾病。根据医疗保险和医疗补助服务中心（CMS.gov）的资料，2023年，美国将在医疗保健方面支出约4.7兆美元，占国民经济的18%。

人们越来越偏好微创治疗

人们对微创手术的日益偏好正在推动血管闭合装置 (VCD) 的进步。 VCD 对于基于导管的干预后有效闭合通路部位至关重要。随着医疗保健转向微创手术以加快患者康復时间并最大限度地减少併发症，VCD 正在不断发展以满足这些需求。现代 VCD 透过使用先进的材料和技术来确保快速、安全地闭合血管网路基地台，从而提高安全性、有效性和患者舒适度。这一趋势反映了医学领域更广泛的趋势，即采用更小切口、更少疼痛和更快恢復正常活动的手术。

临床风险和併发症

血管闭合装置 (VCD) 旨在在基于导管的手术后闭合股动脉通路部位，目的是最大限度地减少出血并加速康復。 VCD 的使用与临床风险和併发症相关，阻碍了其有效性。主要风险包括感染、血肿形成、血管损伤，可导致肢体缺血、血栓症等併发症。也可能存在与设备相关的问题，例如密封不充分或设备移位，这可能导致出血或动脉损伤。

心血管手术增加

随着血管成形术和支架置入术等手术的增加，对高效、安全和有效的 VCD 的需求正在迅速增加。现代VCD旨在快速止血，减少出血和感染等併发症，缩短復原时间。 VCD 技术的创新包括改进材料以实现更好的组织密封、提高临床医生的易用性以及适应各种血管通路部位的设计。这些进步不仅加快了患者的康復速度，还提高了手术效率，并解决了介入心臟病学增加的复杂性和频率。

智慧财产权挑战

由于智慧财产权（IP）问题，血管闭合装置（VCD）产业面临重大挑战。专利纠纷和限制性智慧财产权主张可能会阻止新参与企业开发和销售自己的设备，从而阻碍创新。现有公司通常持有涵盖基础技术的广泛专利，为新兴企业和其他竞争对手设置了障碍。这种情况可能会导致昂贵的法律诉讼并转移研发资源。严格的智慧财产权法规可能会减缓新的、可能更好的设备进入市场的速度，并限制患者照护的进步。结果，市场受到限制，创新放缓，医疗设备成本居高不下，影响了患者的取得和治疗选择。

COVID-19 的影响：

由于选择性手术的中断和医疗保健优先事项的变化，COVID-19 大流行对血管闭合装置 (VCD) 市场产生了重大影响。由于世界各地的医院都专注于治疗新冠肺炎 (COVID-19)严重病例，许多非紧急手术，包括需要血管通路的手术，被推迟或取消。这暂时减少了对 VCD 的需求，VCD 用于在导管手术后关闭动脉通路部位。供应链中断和限制影响了这些仪器的生产和分销。这次疫情也加速了远端和微创诊断技术的采用，进一步影响了 VCD 的传统使用。

预计主动逼近器部分在预测期内将达到最大

预计主动逼近器领域在预测期内将是最大的。主动接近器显着提高了血管闭合装置的有效性和易用性，从而彻底改变了血管闭合装置。这些先进的设备利用动态机制来确保导管插入后留下的穿刺部位闭合。与依赖静压或手动操作的传统被动方法不同，主动逼近器施加受控且可调节的力来精确对准和密封血管开口。这项创新可以实现可靠的闭合，同时最大限度地减少出血和感染等併发症。

预计脑血管介入领域在预测期内复合年增长率最高

预计脑血管介入领域在预测期内复合年增长率最高。脑血管介入领域的重点是提高血管闭合的准确性、降低併发症发生率、缩短恢復时间。现代 VCD 具有创新功能，例如改进的止血剂和适应性闭合机制，以改善进入部位的密封性并最大限度地减少对周围组织的创伤。此外，结合即时影像和先进的追踪系统可以实现更精确的设备放置和监控。

比最大的地区

由于最尖端科技的整合、医疗培训的改善、监管流程的简化等，欧洲地区在预测期内占据最大的市场占有率。先进的 VCD 对于导管插入术等手术后密封动脉穿刺至关重要，该全部区域医疗保健设施和研究的投资正在增加。增强的基础设施正在促进全部区域创新设备的开发和部署，从而提供更高的准确性、安全性和患者舒适度。配备最先进工具和设备的医院和诊所将能够更有效地利用这些先进的 VCD，从而改善手术结果并缩短恢復时间。这些因素正在推动区域成长。

复合年增长率最高的地区：

由于采用血管闭合装置（VCD）并确保严格的安全性和有效性标准，预计欧洲地区在预测期内将显着成长。欧盟的法规结构，包括医疗设备法规 (MDR) 和体外诊断法规 (IVDR)，要求对这些设备进行严格的临床评估、品管措施和上市后监督。这种监管监督透过要求製造商遵守高标准、推动技术进步和改善整个全部区域的患者治疗结果来促进创新。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球血管闭合装置市场：依产品

  • 被动逼近器
  • 主动逼近器
  • 外部止血装置

第六章全球血管闭合装置市场：依接取模式分类

  • 股骨通路
  • 径向访问

第七章全球血管闭合装置市场：依应用分类

  • 週边血管介入治疗
  • 脑血管介入
  • 其他用途

第八章全球血管闭合装置市场：依最终用户分类

  • 医院
  • 心导管实验室
  • 其他最终用户

第九章全球血管闭合装置市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cardinal Health, Inc
  • Endologix, Inc
  • GE Healthcare
  • HeartWare International, Inc
  • Medtronic PLC
  • Nipro Corporation
  • Stryker Corporation
  • Terumo Corporation
Product Code: SMRC27224

According to Stratistics MRC, the Global Vascular Closure Devices Market is accounted for $1.3 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Vascular closure devices (VCDs) are medical instruments designed to seal or close punctures in blood vessels, typically following catheter-based procedures like angiography or percutaneous coronary interventions. These devices are crucial for minimizing bleeding, reducing complications, and expediting recovery by facilitating faster hemostasis at the puncture site. VCDs operate through various mechanisms, including mechanical compression, tissue adhesives, or the deployment of specialized plugs or patches. By effectively sealing the vascular entry point, VCDs help prevent complications such as hematomas, bleeding, or infections, and allow patients to resume normal activities more quickly.

According to the British Heart Foundation, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. According to the data by Centers for Medicare and Medicaid Services (CMS.gov) shows that in 2023, the U.S. spent approximately USD 4.7 trillion on healthcare, constituting 18% of the national economy.

Market Dynamics:

Driver:

Growing preference for minimally invasive procedures

The increasing preference for minimally invasive procedures is driving advancements in Vascular Closure Devices (VCDs), which are crucial for efficiently closing access sites after catheter-based interventions. As healthcare shifts towards less invasive techniques to reduce patient recovery times and minimize complications, VCDs are evolving to meet these demands. Modern VCDs offer improved safety, efficacy, and patient comfort by using advanced materials and technologies to ensure rapid and secure closure of vascular access points. This trend reflects a broader movement in medicine towards procedures that involve smaller incisions, less pain, and quicker returns to normal activities.

Restraint:

Clinical risks and complications

Vascular Closure Devices (VCDs) are designed to close femoral artery access sites after catheter-based procedures, aiming to minimize bleeding and expedite recovery. Their use carries clinical risks and complications that can impede their effectiveness. Key risks include infection, hematoma formation, and vascular injury, which can lead to complications like limb ischemia or thrombosis. There is also the potential for device-related issues such as inadequate sealing or device migration, which can cause bleeding or arterial damage.

Opportunity:

Rise in cardiovascular procedures

As the volume of procedures like angioplasty and stent placements rises, the demand for efficient, safe, and effective VCDs has surged. Modern VCDs are designed to provide faster hemostasis, reduce complications such as bleeding and infection, and shorten recovery times. Innovations in VCD technology include improved materials for better tissue sealing, enhanced ease of use for clinicians, and designs that accommodate various vascular access sites. These advancements not only facilitate quicker patient recovery but also enhance procedural efficiency, aligning with the growing complexity and frequency of cardiovascular interventions.

Threat:

Intellectual property challenges

The vascular closure device (VCD) industry faces significant challenges due to intellectual property (IP) issues. Patent disputes and restrictive IP claims can stifle innovation by preventing new entrants from developing or marketing their own devices. Established companies often hold broad patents that cover fundamental technologies, creating barriers for startups and other competitors. This situation can lead to expensive legal battles, which divert resources away from research and development. Stringent IP regulations can delay the introduction of new, potentially better devices to the market, limiting advancements in patient care. The result is a constrained market where innovation is slowed, and the cost of devices may remain high, impacting accessibility and treatment options for patients.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the vascular closure devices (VCDs) market due to disruptions in elective procedures and a shift in healthcare priorities. As hospitals worldwide focused on managing severe COVID-19 cases, many non-urgent procedures, including those requiring vascular access, were postponed or canceled. This led to a temporary decline in demand for VCDs, which are used to close the arterial access site after catheter-based procedures. Supply chain disruptions and restrictions affected the production and distribution of these devices. The pandemic also accelerated the adoption of remote and less invasive diagnostic techniques, further impacting the traditional usage of VCDs.

The Active Approximators segment is expected to be the largest during the forecast period

Active Approximators segment is expected to be the largest during the forecast period. Active approximators are revolutionizing vascular closure devices by significantly improving their efficacy and ease of use. These advanced devices utilize dynamic mechanisms to securely close the puncture site left after catheterization procedures. Unlike traditional passive methods that rely on static pressure or manual manipulation, active approximators apply controlled, adjustable forces to precisely align and seal the vascular opening. This innovation enhances the device's ability to achieve a reliable closure with minimal complications, such as bleeding or infection.

The Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period

Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period. Cerebrovascular Interventions segment focus on increasing the precision of vascular closure, reducing complication rates, and shortening recovery times. Modern VCDs are designed with innovative features such as improved hemostatic agents and more adaptable closure mechanisms, which ensure better sealing of the access site and minimal trauma to surrounding tissues. Additionally, the incorporation of real-time imaging and advanced tracking systems allows for more accurate device placement and monitoring.

Region with largest share:

Europe region commanded the largest market share over the extrapolated period driven by the integration of cutting-edge technologies, improved medical training, and streamlined regulatory processes. Advanced VCDs, which are crucial for sealing arterial punctures after procedures like catheterizations, are benefiting from increased investment in healthcare facilities and research across the region. Enhanced infrastructure facilitates the development and deployment of innovative devices that offer greater precision, safety, and patient comfort throughout the region. Hospitals and clinics equipped with state-of-the-art tools and facilities can more effectively utilize these advanced VCDs, leading to improved procedural outcomes and reduced recovery times. These elements are boosting the regional growth.

Region with highest CAGR:

Europe region is projected to witness substantial growth during the forecast period due to the adoption of Vascular Closure Devices (VCDs) by ensuring stringent safety and efficacy standards. The European Union's regulatory framework, including the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), mandates rigorous clinical evaluations, quality control measures, and post-market surveillance for these devices. This regulatory oversight fosters innovation by encouraging manufacturers to adhere to high standards, thus driving advancements in technology and improving patient outcomes across the region.

Key players in the market

Some of the key players in Vascular Closure Devices market include Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc, Endologix, Inc, GE Healthcare, HeartWare International, Inc, Medtronic PLC, Nipro Corporation, Stryker Corporation and Terumo Corporation.

Key Developments:

In June 2024, Haemonetics Corporation has announced the launch of its new VASCADE MVP XL mid-bore venous closure device. The VASCADE MVP XL system adds to Haemonetics VASCADE line of vascular closure devices by using novel collapsible disc technology with a patented resorbable collagen patch that promotes fast hemostasis.

In November 2023, Johnson & Johnson Service Inc., a biotechnology company, announced the completion of the acquisition of Laminar, Inc., a privately held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

In February 2023, the LockeT product was introduced to the market by Catheter Precision, Inc., a wholly-owned subsidiary of Ra Medical Systems, Inc. The first shipments of the product to its distributors will start right away. When a catheter is inserted through the skin into a blood artery and subsequently removed after an operation, LockeT can be utilized in combination with the closure of the percutaneous wound site.

Products Covered:

  • Passive Approximators
  • Active Approximators
  • External Haemostatic Devices

Access Modes Covered:

  • Femoral Access
  • Radial Access

Applications Covered:

  • Peripheral Vascular Interventions
  • Cerebrovascular Interventions
  • Other Applications

End Users Covered:

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vascular Closure Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Passive Approximators
  • 5.3 Active Approximators
  • 5.4 External Haemostatic Devices

6 Global Vascular Closure Devices Market, By Access Mode

  • 6.1 Introduction
  • 6.2 Femoral Access
  • 6.3 Radial Access

7 Global Vascular Closure Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Peripheral Vascular Interventions
  • 7.3 Cerebrovascular Interventions
  • 7.4 Other Applications

8 Global Vascular Closure Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Cardiac Catheterization Laboratories
  • 8.4 Other End Users

9 Global Vascular Closure Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Boston Scientific Corporation
  • 11.3 Cardinal Health, Inc
  • 11.4 Endologix, Inc
  • 11.5 GE Healthcare
  • 11.6 HeartWare International, Inc
  • 11.7 Medtronic PLC
  • 11.8 Nipro Corporation
  • 11.9 Stryker Corporation
  • 11.10 Terumo Corporation

List of Tables

  • Table 1 Global Vascular Closure Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 4 Global Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 5 Global Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 6 Global Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 7 Global Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 8 Global Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 9 Global Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 10 Global Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 11 Global Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 12 Global Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 13 Global Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 15 Global Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 16 Global Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 17 North America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 18 North America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 19 North America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 20 North America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 21 North America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 22 North America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 23 North America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 24 North America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 25 North America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 27 North America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 28 North America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 29 North America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 North America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 North America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 32 North America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 33 Europe Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 34 Europe Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 35 Europe Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 36 Europe Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 37 Europe Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 38 Europe Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 39 Europe Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 40 Europe Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 41 Europe Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 42 Europe Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 43 Europe Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 44 Europe Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 45 Europe Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 46 Europe Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 47 Europe Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 48 Europe Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 49 Asia Pacific Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Asia Pacific Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 51 Asia Pacific Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 52 Asia Pacific Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 53 Asia Pacific Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 54 Asia Pacific Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 55 Asia Pacific Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 56 Asia Pacific Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 57 Asia Pacific Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Asia Pacific Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 59 Asia Pacific Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 60 Asia Pacific Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 61 Asia Pacific Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Asia Pacific Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 63 Asia Pacific Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 64 Asia Pacific Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 65 South America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 66 South America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 67 South America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 68 South America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 69 South America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 70 South America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 71 South America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 72 South America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 73 South America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 South America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 75 South America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 76 South America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 77 South America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 78 South America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 79 South America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 80 South America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 81 Middle East & Africa Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 Middle East & Africa Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 83 Middle East & Africa Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
  • Table 84 Middle East & Africa Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
  • Table 85 Middle East & Africa Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
  • Table 86 Middle East & Africa Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
  • Table 87 Middle East & Africa Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
  • Table 88 Middle East & Africa Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
  • Table 89 Middle East & Africa Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 90 Middle East & Africa Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
  • Table 91 Middle East & Africa Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
  • Table 92 Middle East & Africa Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 93 Middle East & Africa Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 94 Middle East & Africa Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 95 Middle East & Africa Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
  • Table 96 Middle East & Africa Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)